BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 27434654)

  • 41. TAK1 regulates caspase 8 activation and necroptotic signaling via multiple cell death checkpoints.
    Guo X; Yin H; Chen Y; Li L; Li J; Liu Q
    Cell Death Dis; 2016 Sep; 7(9):e2381. PubMed ID: 27685625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Necroptosis Signaling Pathways in Stroke: From Mechanisms to Therapies.
    Jun-Long H; Yi L; Bao-Lian Z; Jia-Si L; Ning Z; Zhou-Heng Y; Xue-Jun S; Wen-Wu L
    Curr Neuropharmacol; 2018; 16(9):1327-1339. PubMed ID: 29663889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chemical regulation of signaling pathways to programmed necrosis.
    Bae JH; Shim JH; Cho YS
    Arch Pharm Res; 2014 Jun; 37(6):689-97. PubMed ID: 24715577
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction.
    Luedde M; Lutz M; Carter N; Sosna J; Jacoby C; Vucur M; Gautheron J; Roderburg C; Borg N; Reisinger F; Hippe HJ; Linkermann A; Wolf MJ; Rose-John S; Lüllmann-Rauch R; Adam D; Flögel U; Heikenwalder M; Luedde T; Frey N
    Cardiovasc Res; 2014 Jul; 103(2):206-16. PubMed ID: 24920296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Necroptosis is a key mediator of enterocytes loss in intestinal ischaemia/reperfusion injury.
    Wen S; Ling Y; Yang W; Shen J; Li C; Deng W; Liu W; Liu K
    J Cell Mol Med; 2017 Mar; 21(3):432-443. PubMed ID: 27677535
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Necroptosis: Pathway diversity and characteristics.
    de Almagro MC; Vucic D
    Semin Cell Dev Biol; 2015 Mar; 39():56-62. PubMed ID: 25683283
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
    Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
    Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction Mechanism of Ferroptosis, Necroptosis, and Pyroptosis: A Novel Therapeutic Target in Nervous System Diseases.
    Tang L; Liu S; Li S; Chen Y; Xie B; Zhou J
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MutY DNA Glycosylase Protects Cells From Tumor Necrosis Factor Alpha-Induced Necroptosis.
    Tran AHV; Han SH; Kim J; Grasso F; Kim IS; Han YS
    J Cell Biochem; 2017 Jul; 118(7):1827-1838. PubMed ID: 28059467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.
    Park JH; Jung KH; Kim SJ; Yoon YC; Yan HH; Fang Z; Lee JE; Lim JH; Mah S; Hong S; Kim YS; Hong SS
    Cancer Lett; 2019 Mar; 444():94-104. PubMed ID: 30583075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome.
    Zhang Y; Su SS; Zhao S; Yang Z; Zhong CQ; Chen X; Cai Q; Yang ZH; Huang D; Wu R; Han J
    Nat Commun; 2017 Feb; 8():14329. PubMed ID: 28176780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Manipulation of necroptosis by Porphyromonas gingivalis in periodontitis development.
    Ke X; Lei L; Li H; Li H; Yan F
    Mol Immunol; 2016 Sep; 77():8-13. PubMed ID: 27449906
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Necroptosis regulates tumor repopulation after radiotherapy via RIP1/RIP3/MLKL/JNK/IL8 pathway.
    Wang Y; Zhao M; He S; Luo Y; Zhao Y; Cheng J; Gong Y; Xie J; Wang Y; Hu B; Tian L; Liu X; Li C; Huang Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):461. PubMed ID: 31706322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of necroptosis in cancer: A double-edged sword?
    Qin X; Ma D; Tan YX; Wang HY; Cai Z
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):259-266. PubMed ID: 30716362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surveying the landscape of emerging and understudied cell death mechanisms.
    Leak L; Dixon SJ
    Biochim Biophys Acta Mol Cell Res; 2023 Mar; 1870(3):119432. PubMed ID: 36690038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma.
    Dong L; Vargas CPD; Tian X; Chu X; Yin C; Wong A; Yang Y
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373523
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.
    Feldmann F; Schenk B; Martens S; Vandenabeele P; Fulda S
    Oncotarget; 2017 Sep; 8(40):68208-68220. PubMed ID: 28978109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pore formation in regulated cell death.
    Flores-Romero H; Ros U; Garcia-Saez AJ
    EMBO J; 2020 Dec; 39(23):e105753. PubMed ID: 33124082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of necroptotic proteins in failing human hearts.
    Szobi A; Gonçalvesová E; Varga ZV; Leszek P; Kuśmierczyk M; Hulman M; Kyselovič J; Ferdinandy P; Adameová A
    J Transl Med; 2017 Apr; 15(1):86. PubMed ID: 28454582
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer therapy in the necroptosis era.
    Su Z; Yang Z; Xie L; DeWitt JP; Chen Y
    Cell Death Differ; 2016 May; 23(5):748-56. PubMed ID: 26915291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.